PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions

Vitrectomy

Interventions

DRUG

Dexamethasone Phosphate Ophthalmic Solution

Experimental: Dexamethasone Phosphate Ophthalmic Solution (40 mg/mL) delivered via the EyeGate II Drug Delivery System

Trial Locations (1)

Ophthalmic Consultants of Boston, Boston